> Details

Ribas, Antoni; Puzanov, Igor; Gajewski, Thomas; Long, Georgina V.; Dummer, Reinhard; Kirkwood, John M.; VanderWalde, Ari; Cebon, Jonathan S.; McArthur, Grant A.; Gause, Christine K.; Chen, Lisa; Kaufman, David Ross; Chou, Jeffrey; Andtbacka, Robert Hans Ingemar; Hodi, F. Stephen

A multicenter, open-label trial of talimogene laherparepvec (T-VEC) plus pembrolizumab vs pembrolizumab monotherapy in previously untreated, unresected, stage IIIB-IV melanoma

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: A multicenter, open-label trial of talimogene laherparepvec (T-VEC) plus pembrolizumab vs pembrolizumab monotherapy in previously untreated, unresected, stage IIIB-IV melanoma
  • Contributor: Ribas, Antoni; Puzanov, Igor; Gajewski, Thomas; Long, Georgina V.; Dummer, Reinhard; Kirkwood, John M.; VanderWalde, Ari; Cebon, Jonathan S.; McArthur, Grant A.; Gause, Christine K.; Chen, Lisa; Kaufman, David Ross; Chou, Jeffrey; Andtbacka, Robert Hans Ingemar; Hodi, F. Stephen
  • Published: American Society of Clinical Oncology (ASCO), 2015
  • Published in: Journal of Clinical Oncology, 33 (2015) 15_suppl, Seite TPS9081-TPS9081
  • Language: English
  • DOI: 10.1200/jco.2015.33.15_suppl.tps9081
  • ISSN: 0732-183X; 1527-7755
  • Origination:
  • Footnote:
  • Access State: Open Access